IP Verse

Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect - EP3368071

PATENT ANALYSIS

Patent Details

Grant Date
Jan 26, 2022
Company
REVANCE THERAPEUTICS, INC.
Oppositions

IPSEN BIOPHARMA LIMITED

More patents of Revance Therapeutics, Inc.

EP2490986

EP3368071

EP2661276

Want to monitor this patent?

Feel free to send us a message here and we will get back to you